Relapsed Acute Lymphoblastic Leukemia (ALL) Completed Phase 1 Trials for Pevonedistat (DB11759)

Back to Relapsed Acute Lymphoblastic Leukemia (ALL)

Also known as: Acute Lymphoblastic Leukemia, in Relapse / Relapsed ALL / Relapsed Acute Lymphoblastic Leukemia / Acute, relapsed Lymphoblastic Leukemia

Indication	Status	Phase
DBCOND0069491 (Relapsed Acute Lymphoblastic Leukemia (ALL))	Completed	1

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT03349281	Pevonedistat With VXLD Chemotherapy for Adolescent/Young Adults With Relapsed/Refractory ALL or Lymphoblastic NHL	Treatment	Asparaginase Escherichia coli (DB00023) Cytarabine (DB00987) Dexamethasone (DB01234) Doxorubicin (DB00997) Hydrocortisone (DB00741) Methotrexate (DB00563) Pegaspargase (DB00059) Pevonedistat (DB11759) Vincristine (DB00541)